Related citations 187 items
-
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.
Review article
Korde N, et al.
Blood. 2011
-
Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management.
Review article
Hillengass J, et al.
Recent Results Cancer Res. 2011
-
Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Review article
van de Donk NW, et al.
Int J Lab Hematol. 2016
-
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies.
Review article
Landgren O, et al.
Hematology Am Soc Hematol Educ Program. 2013
-
Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
Magnano L, et al.
Clin Lymphoma Myeloma Leuk. 2016
-
MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology.
Review article
Mateos MV, et al.
Cancer Treat Res. 2016
-
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease.
Review article
Agarwal A, et al.
Clin Cancer Res. 2013
-
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
Review article
Kyle RA, et al.
Leukemia. 2010
-
Asymptomatic monoclonal gammopathies.
Review article
Bories C, et al.
Clin Lymphoma Myeloma Leuk. 2014
-
Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
Golombick T, et al.
Integr Cancer Ther. 2016